368 related articles for article (PubMed ID: 16881100)
1. Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis.
Cleland LG; Caughey GE; James MJ; Proudman SM
J Rheumatol; 2006 Oct; 33(10):1973-9. PubMed ID: 16881100
[TBL] [Abstract][Full Text] [Related]
2. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis.
Adam O; Beringer C; Kless T; Lemmen C; Adam A; Wiseman M; Adam P; Klimmek R; Forth W
Rheumatol Int; 2003 Jan; 23(1):27-36. PubMed ID: 12548439
[TBL] [Abstract][Full Text] [Related]
4. Collateral benefits of fish oil therapy for rheumatoid arthritis.
Lau CS
J Rheumatol; 2006 Oct; 33(10):1931-3. PubMed ID: 17014011
[No Abstract] [Full Text] [Related]
5. Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use.
Proudman SM; James MJ; Spargo LD; Metcalf RG; Sullivan TR; Rischmueller M; Flabouris K; Wechalekar MD; Lee AT; Cleland LG
Ann Rheum Dis; 2015 Jan; 74(1):89-95. PubMed ID: 24081439
[TBL] [Abstract][Full Text] [Related]
6. Low dose supplementation with two different marine oils does not reduce pro-inflammatory eicosanoids and cytokines in vivo.
Murphy KJ; Galvin K; Kiely M; Morrissey PA; Mann NJ; Sinclair AJ
Asia Pac J Clin Nutr; 2006; 15(3):418-24. PubMed ID: 16837436
[TBL] [Abstract][Full Text] [Related]
7. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
9. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
[TBL] [Abstract][Full Text] [Related]
10. Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritis.
Proudman SM; Cleland LG; Metcalf RG; Sullivan TR; Spargo LD; James MJ
Br J Nutr; 2015 Sep; 114(6):885-90. PubMed ID: 26283657
[TBL] [Abstract][Full Text] [Related]
11. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
Gubar' EE; Bochkova AG; Bunchuk NV
Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
[TBL] [Abstract][Full Text] [Related]
13. Abnormal fatty acid pattern in rheumatoid arthritis. A rationale for treatment with marine and botanical lipids.
Navarro E; Esteve M; Olivé A; Klaassen J; Cabré E; Tena X; Fernández-Bañares F; Pastor C; Gassull MA
J Rheumatol; 2000 Feb; 27(2):298-303. PubMed ID: 10685788
[TBL] [Abstract][Full Text] [Related]
14. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
[TBL] [Abstract][Full Text] [Related]
15. Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients.
Georgiadis AN; Voulgari PV; Argyropoulou MI; Alamanos Y; Elisaf M; Tselepis AD; Drosos AA
Semin Arthritis Rheum; 2008 Aug; 38(1):13-9. PubMed ID: 18191989
[TBL] [Abstract][Full Text] [Related]
16. [Nutrition as adjuvant therapy in chronic polyarthritis].
Adam O
Z Rheumatol; 1993; 52(5):275-80. PubMed ID: 8259718
[TBL] [Abstract][Full Text] [Related]
17. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK; Kostkiewicz M
Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
[TBL] [Abstract][Full Text] [Related]
19. [Fish fatty acids and cardiovascular diseases--an update].
Brouwer IA; Katan MB
Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2009-14. PubMed ID: 18825888
[TBL] [Abstract][Full Text] [Related]
20. The effect of fish oil on physical aggression in schoolchildren--a randomized, double-blind, placebo-controlled trial.
Itomura M; Hamazaki K; Sawazaki S; Kobayashi M; Terasawa K; Watanabe S; Hamazaki T
J Nutr Biochem; 2005 Mar; 16(3):163-71. PubMed ID: 15741051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
